Life Sciences market research reports by China Research and Intelligence Co., Ltd.

• Investigation Report on China's Aflibercept Market 2022-2031

  Jul 25, 2022  |  Published by: China Research and Intelligence Co., Ltd.  |  USD 3,200

  Investigation Report on China's Aflibercept Market 2022-2031 Aflibercept is an anti-VEGF drug, mainly used to treat neovascular age-related macular degeneration (wAMD), and other retinopathy caused by visual impairment. Aflibercept was jointly developed by Regeneron and Bayer. Regeneron has exclusiv ... Read More

• Research Report on China's Nicorandil Market, 2022-2031

  Jul 25, 2022  |  Published by: China Research and Intelligence Co., Ltd.  |  USD 3,600

  Research Report on China's Nicorandil Market, 2022-2031 In China, the crude incidence rate of hypertension among residents over the age of 18 is close to 30%, and the most common hazard of hypertension is coronary heart disease. By the end of 2021, it is estimated that the number of patients with co ... Read More

• Investigation Report on China's Shingles Vaccine Market 2022-2031

  Jul 25, 2022  |  Published by: China Research and Intelligence Co., Ltd.  |  USD 3,200

  Investigation Report on China's Shingles Vaccine Market 2022-2031 The trade name of shingles vaccine (recombinant zoster vaccine) is SHINGRIX, which was developed by GlaxoSmithKline. Its product was firstly approved in China in 2020. Shingles vaccine is suitable for adults aged 50 years and over to ... Read More

< prev 1 2 next >